Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers

Lung cancer is the leading cause of cancer-related deaths worldwide. The standard of care for advanced non-small-cell lung cancer (NSCLC) without driver-gene mutations is a combination of an anti-PD-1/PD-L1 antibody and chemotherapy, or an anti-PD-1/PD-L1 antibody and an anti-CTLA-4 antibody with or...

Descripción completa

Detalles Bibliográficos
Autores principales: Muto, Satoshi, Enta, Akio, Maruya, Yoshiyuki, Inomata, Sho, Yamaguchi, Hikaru, Mine, Hayato, Takagi, Hironori, Ozaki, Yuki, Watanabe, Masayuki, Inoue, Takuya, Yamaura, Takumi, Fukuhara, Mitsuro, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Osugi, Jun, Hoshino, Mika, Higuchi, Mitsunori, Shio, Yutaka, Hamada, Kazuyuki, Suzuki, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855612/
https://www.ncbi.nlm.nih.gov/pubmed/36672698
http://dx.doi.org/10.3390/biomedicines11010190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855612/
https://www.ncbi.nlm.nih.gov/pubmed/36672698
http://dx.doi.org/10.3390/biomedicines11010190

Ejemplares similares